Skip to main content
CORCEPT THERAPEUTICS INC logo

CORCEPT THERAPEUTICS INC — Investor Relations & Filings

Ticker · CORT ISIN · US2183521028 LEI · 529900EO9LUTFMZ7FF90 US Manufacturing
Open in API
Filings indexed 1,287 across all filing types
Latest filing 2026-06-03 Legal Proceedings Report
Country US United States of America
Listing US CORT

About CORCEPT THERAPEUTICS INC

https://www.corcept.com/

Corcept Therapeutics Inc. is a commercial-stage pharmaceutical company engaged in the discovery, development, and commercialization of medications. The company focuses on cortisol modulation, developing molecules that regulate cortisol activity at the glucocorticoid receptor (GR). Its primary mission is to create novel treatments for severe disorders. Corcept's research and development efforts span multiple therapeutic areas, including endocrinology, oncology, metabolism, and neurology, aiming to address serious diseases impacted by cortisol.

Recent filings

Filing Released Lang Actions
8-K
Legal Proceedings Report Classification · 88% confidence The document is a Form 8-K “Current Report” describing Item 8.01 “Other Events” – specifically, the DOJ’s Notice declining intervention in a qui tam lawsuit and the relator’s amended complaint. This is an update on significant legal proceedings. Under the filing definitions, such updates on lawsuits and regulatory/legal actions fall under Legal Proceedings Report (Code: LTR).
2026-06-03 English
S-8
Share Issue/Capital Change Classification · 92% confidence The document is a Form S-8 SEC registration statement filed under the Securities Act of 1933, registering 8,000,000 additional shares for issuance under the company’s 2024 Incentive Award Plan. A Form S-8 is used to register new equity issuances (employee/compensation plan shares). This fits the “Share Issue/Capital Change” category (SHA).
2026-05-29 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report that primarily contains the submission of matters to a vote at the 2026 Annual Meeting of Stockholders, including detailed vote counts for election of directors, ratification of the independent accountant, advisory approval of executive compensation, and amendment to the incentive award plan. This is a formal declaration of voting results. Therefore, it falls under Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-28 English
DEF 14A - CORCEPT THERAPEUTICS INC (0001088856) (Filer)
Proxy Solicitation & Information Statement
2026-04-17 English
4 - CORCEPT THERAPEUTICS INC (0001088856) (Issuer)
Director's Dealing
2026-03-27 English
SCHEDULE 13G/A - CORCEPT THERAPEUTICS INC (0001088856) (Subject)
Major Shareholding Notification
2026-03-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.